ALLADDIN ABOSAIDA

Allopathic & Osteopathic Physicians|Pediatrics|Pediatric Pulmonology WEST DES MOINES, IA NPI 1376777524

General Payments — all program years on this page

$1,526.81

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 74
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $396.41 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $396.4120

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $299.3924
2019 $368.065
2022 $107.007
2023 $355.9518
2024 $396.4120

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086766365 Novartis Pharmaceuticals Corporation $16.40 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1099888359 ALK-Abello, Inc $14.42 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104531820 AstraZeneca Pharmaceuticals LP $26.21 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104599260 AstraZeneca Pharmaceuticals LP $16.13 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104656513 AstraZeneca Pharmaceuticals LP $26.09 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104702193 AstraZeneca Pharmaceuticals LP $22.43 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105526227 AstraZeneca Pharmaceuticals LP $15.50 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105702848 AstraZeneca Pharmaceuticals LP $18.25 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105738033 AstraZeneca Pharmaceuticals LP $34.75 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111508309 Amgen Inc. $13.42 07/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113993401 Regeneron Healthcare Solutions, Inc. $20.80 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1113993403 Regeneron Healthcare Solutions, Inc. $16.65 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131714459 PFIZER INC. $19.25 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132974361 Genentech USA, Inc. $14.74 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132974363 Genentech USA, Inc. $31.68 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132974365 Genentech USA, Inc. $16.53 11/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134613551 CSL Behring $32.11 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139652089 GENZYME CORPORATION $13.63 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139652111 GENZYME CORPORATION $13.29 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139652151 GENZYME CORPORATION $14.13 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.